[1] Sermorelin has no current FDA product
In the Phase 3 TRIUMPH-1 trial reported in 2026, patients on the 12 mg dose lost an average of 28.3% of their body weight over 80 weeks, compared with just 2.2% for placebo (Eli Lilly, 2026)
The research was peer-reviewed by the congress organizers, the European Association for the Study of Obesity, but the paper is not yet available
"L-Carnitine Tartrate Supplementation for 5 Weeks Improves Exercise Recovery in Men and Women: A Randomized, Double-Blind, Placebo-Controlled Trial." Nutrients
Ipamorelin + Epithalon + CJC-1295 No DAC Nasal Spray's Mechanism of Action in Research Models Ipamorelin is studied for its ability to activate the growth hormone secretagogue receptor (GHS-R1a) in research models
GLP1 Weight Loss Shots | Austin, TX GLP1 weight loss shots represent a significant breakthrough in addressing the unique challenges of menopause weight gain, offering hope for women who have struggled with traditional approaches